Fidelity Select Medical Technology and Devices Portfolio FSMEX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 55.82  /  +0.70 %
  • Total Assets 3.5B
  • Adj. Expense Ratio
    0.620%
  • Expense Ratio 0.620%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.00
  • Turnover 54%

USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0

Morningstar’s Analysis FSMEX

Will FSMEX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Fidelity Select Medical Tech and Devcs holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FSMEX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 63.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Thermo Fisher Scientific Inc

17.59 589M
Healthcare

Danaher Corp

14.04 470M
Healthcare

Intuitive Surgical Inc

5.29 177M
Healthcare

Waters Corp

4.27 143M
Healthcare

West Pharmaceutical Services Inc

4.08 136M
Healthcare

Agilent Technologies Inc

3.90 131M
Healthcare

Boston Scientific Corp

3.85 129M
Healthcare

10x Genomics Inc Ordinary Shares - Class A

3.73 125M
Healthcare

Abbott Laboratories

3.46 116M
Healthcare

Stryker Corp

3.19 107M
Healthcare

Sponsor Center